Elevation Oncology (NASDAQ:ELEV) Lifted to Outperform at SVB Securities
SVB Securities upgraded shares of Elevation Oncology (NASDAQ:ELEV – Get Rating) from a market perform rating to an outperform rating in a report released on Tuesday morning, The Fly reports. They currently have $8.00 price objective on the stock, up from their previous price objective of $5.00. Separately, Wedbush reaffirmed an outperform rating and issued […]